CLINICAL_TRIALS trial_result · 2012-10-12

Clinical Trial Update: Dasatinib in Relapsed Chronic Lymphocytic Leukemia [Phase 2]

A Phase 2 clinical trial evaluating dasatinib in relapsed chronic lymphocytic leukemia has been completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Massachusetts General Hospital | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2012-10-12